## **Core Concept**
Non-depolarizing neuromuscular blockers work by competitively inhibiting the **nicotinic acetylcholine receptors** at the neuromuscular junction, thereby preventing acetylcholine from triggering muscle contraction. This type of blockade can be influenced by various factors that alter the concentration or function of acetylcholine or the sensitivity of the receptors.

## **Why the Correct Answer is Right**
The correct answer, **Magnesium**, potentiates non-depolarizing blockade by decreasing the release of acetylcholine from the nerve terminal and also by reducing the sensitivity of the muscle to acetylcholine. This results in an enhanced blockade when magnesium is administered concurrently with non-depolarizing neuromuscular blockers.

## **Why Each Wrong Option is Incorrect**
- **Option A: Aminoglycosides** can also potentiate neuromuscular blockade but through a mechanism involving interference with calcium ion entry into the nerve terminal, which decreases acetylcholine release. However, they are not the best answer here given the context.
- **Option B: Calcium** would actually counteract the effects of non-depolarizing blockade by facilitating neurotransmitter release, making it incorrect as a potentiator.
- **Option D: Potassium** does not have a direct potentiating effect on non-depolarizing neuromuscular blockade like magnesium does.

## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that **magnesium sulfate** can significantly potentiate non-depolarizing neuromuscular blockade. This is particularly relevant in obstetric anesthesia where magnesium is used for eclampsia prophylaxis and treatment. Clinicians must be cautious with the timing and dosing of neuromuscular blockers in patients receiving magnesium.

## **Correct Answer:** .